In summary, we propose that treatment with CVB-D in lung cancer cells can provoke mitophagy through the p65/BNIP3/LC3 axis, and that this overactivated mitophagy is one of the contributing factors in apoptosis induction. The gene discussed is MAP1LC3A; the disease is lung carcinoma.